Zai Lab
ZLAB

Zai Lab (ZLAB) earnings history

Most recent quarter

Period end
Jun 30, 2026
EPS actual
−$0.50
EPS estimate
−$0.64
Revenue
$106.3M
Reported
Aug 6, 2026

Zai Lab reported Q2 2026 results on August 6, 2026. It posted a loss of $0.50 per share, narrower than the $0.64 loss expected, a 21.59% beat. Revenue of $106.3 million beat the $103.5 million consensus by 2.74%. Compared with Q2 2025, the loss widened from $0.37 per share and revenue fell about 3% from $110.0 million.

Every quarter in the table is a loss. Annual losses narrowed each year, from $4.63 per share in 2022 to $3.46 in 2023, $2.59 in 2024 and $1.61 in 2025. Revenue more than doubled over the same span, from $215.0 million to $460.2 million, and peaked at $127.6 million in Q4 2025. Revenue in both 2026 quarters was below the year-earlier level, and the first-half loss of $0.96 per share is wider than the $0.82 a year earlier. Results against estimates have been mixed, with 10 beats and 10 misses over the last 20 quarters.

Zai Lab reported its third quarter between November 6 and November 12 in each of the past five years. That points to early-to-mid November 2026 for the Q3 report. It will show whether revenue returns to year-over-year growth and whether the loss narrows again.

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2026Aug 6, 2026−$0.64−$0.50+21.59%$106.3MSEC
Q1 2026May 7, 2026−$0.53−$0.46+12.58%$99.6MSEC
Q4 2025Feb 26, 2026−$0.36−$0.46−28.13%$127.6MSEC
Q3 2025Nov 6, 2025−$0.29−$0.33−14.23%$116.1MSEC
Q2 2025Aug 7, 2025−$0.36−$0.37−3.27%$110.0MSEC
Q1 2025May 8, 2025−$0.55−$0.45+18.73%$106.5MSEC
Q4 2024Feb 27, 2025−$0.65−$0.80−22.87%$109.1MSEC
Q3 2024Nov 12, 2024−$0.78−$0.42+46.35%$102.3MSEC
Q2 2024Aug 6, 2024−$0.71−$0.82−15.75%$100.1MSEC
Q1 2024May 8, 2024−$0.92−$0.55+40.53%$87.1MSEC
Q4 2023Feb 27, 2024−$0.86−$1.63−90.47%$65.8MSEC
Q3 2023Nov 7, 2023−$1.04−$0.07+93.30%$69.2MSEC
Q2 2023Aug 7, 2023−$0.79−$1.25−58.15%$68.9MSEC
Q1 2023May 9, 2023−$0.95−$0.51+46.21%$62.8MSEC
Q4 2022Mar 1, 2023−$1.11−$0.65+41.40%$62.6MSEC
Q3 2022Nov 9, 2022−$1.25−$1.68−34.54%$57.5MSEC
Q2 2022Aug 9, 2022−$1.08−$1.44−33.87%$48.2MSEC
Q1 2022May 10, 2022−$1.26−$0.86+31.76%$46.7M—
Q4 2021Mar 1, 2022−$1.33−$2.17−62.69%$44.2M—
Q3 2021Nov 9, 2021−$1.18−$1.01+14.27%$43.1M—

Quarterly revenue

Q3 2021
$43.1M
Q4 2021
$44.2M
Q1 2022
$46.7M
Q2 2022
$48.2M
Q3 2022
$57.5M
Q4 2022
$62.6M
Q1 2023
$62.8M
Q2 2023
$68.9M
Q3 2023
$69.2M
Q4 2023
$65.8M
Q1 2024
$87.1M
Q2 2024
$100.1M
Q3 2024
$102.3M
Q4 2024
$109.1M
Q1 2025
$106.5M
Q2 2025
$110.0M
Q3 2025
$116.1M
Q4 2025
$127.6M
Q1 2026
$99.6M
Q2 2026
$106.3M

Frequently asked questions

  • When did Zai Lab (ZLAB) last report earnings?

    Zai Lab last reported on Aug 6, 2026, covering fiscal Q2 2026.

  • Did ZLAB beat earnings estimates?

    Yes. Zai Lab reported EPS of −$0.50 for Q2 2026 against a −$0.64 estimate — a 21.59% beat.

  • How much revenue did ZLAB report last quarter?

    Zai Lab reported $106.3M in revenue for Q2 2026, against a consensus estimate of $103.5M.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.